Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. financial statements
Apimeds Pharmaceuticals US, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 6M | 10-K |
| Cash and equivalents | USD 144.6K | 10-Q |
| Total debt | USD 7.76M | EODHD |
Apimeds Pharmaceuticals US, Inc. financials on 6ix · Apimeds Pharmaceuticals US, Inc. on 6ix